Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

19.24 -0.25 (-1.28%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
From CareDx, Inc.
Via Business Wire
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
From CareDx, Inc.
Via Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Announces $50 Million Stock Repurchase Program
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
From CareDx, Inc.
Via Business Wire
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
From CareDx, Inc.
Via Business Wire
CareDx To Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
CareDx Reports Third Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
From CareDx, Inc.
Via Business Wire
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
From CareDx, Inc.
Via Business Wire
CareDx to Report Third Quarter 2022 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
From CareDx, Inc.
Via Business Wire
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions
From CareDx, Inc.
Via Business Wire
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List
From CareDx, Inc.
Via Business Wire
NASDAQ: CDNA Long Term Investor Alert: Investigation of Potential Wrongdoing at CareDx, Inc
San Diego, CA -- (SBWIRE) -- 09/19/2022 -- Certain directors of CareDx, Inc are under investigation over potential breaches of fiduciary duties by certain directors of CareDx, Inc. 
Via SBWire
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference
From CareDx, Inc.
Via Business Wire
CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society
From CareDx, Inc.
Via Business Wire
CareDx and MOTTEP Co-Host Health Equity Summit
From CareDx, Inc.
Via Business Wire
CareDx Reports Second Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App
From CareDx, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback